Spectral AI, Inc. (MDAI) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

11/25

Growth 2 Margin 1 Expansion 3 Platform 2 Financial 3

latest quarter score

Earnings Reports

11
Spectral AI (MDAI) Q2 2026: FDA De Novo Clearance Catalyzes Transition to Commercial Launch with $14M Cash Backing
August 12, 2026
10
Spectral AI (MDAI) Q1 2026: $31.7M BARDA Acceleration Anchors DeepView Commercialization Timeline
May 13, 2026
11
Spectral AI (MDAI) Q4 2025: BARDA $31.7M Acceleration Sets Up DeepView Commercial Pivot
March 25, 2026
7
Spectral AI (MDAI) Q3 2025: Revenue Falls 54% as BARDA Work Winds Down, Commercial Launch in Sight
November 12, 2025
9
Spectral AI (MDAI) Q2 2025: $10.5M Cash Bolsters FDA Commercialization Runway
August 12, 2025
12
Spectral AI (MDAI) Q1 2025: 6% Revenue Growth Anchors FDA Submission Momentum
May 13, 2025
12
Spectral AI (MDAI) Q4 2024: Burn Validation Study Propels Regulatory Progress and Commercial Readiness
March 27, 2025

Browse all companies